Literature DB >> 17379167

Poly(ethylene glycol)-modified thiolated gelatin nanoparticles for glutathione-responsive intracellular DNA delivery.

Sushma Kommareddy1, Mansoor Amiji.   

Abstract

Poly(ethylene glycol) (PEG)-modified thiolated gelatin (PEG-SHGel) anoparticles were developed as a long-circulating passively targeted delivery system that responds to intracellular glutathione concentrations to enhance DNA delivery and transfection. Reporter plasmid expressing enhanced green fluorescent protein (EGFP-N1) was encapsulated in the nanoparticles. DNA-containing gelatin (Gel) and thiolated gelatin (SHGel) nanoparticles were found to have a size range of 220 to 250 nm, whereas surface modification with PEG resulted in particles with a slightly larger size range of 310 to 350 nm. PEG modification was confirmed by electron spectroscopy for chemical analysis (ESCA), where an increase in the ether peak intensities of the C1s spectra corresponds to the surface presence of ethylene oxide residues. In addition, the PEG-SHGel nanoparticles released encapsulate plasmid DNA in response to varying concentrations of glutathione (up to 5.0 mM GSH in phosphate-buffered saline, or PBS). The stability of the encapsulated DNA was confirmed by agarose gel electrophoresis. Finally, from the qualitative and quantitative results of in vitro transfection studies in murine fibroblast cells (NIH3T3), PEG-Gel and PEG-SHGel nanoparticles afforded the highest transfection efficiency of the reporter plasmid. The results of these studies show that PEG-modified thiolated gelatin nanoparticles could serve as a very efficient nanoparticulate vector for systemic DNA delivery to solid tumors where the cells are known to have significantly higher intracellular GSH concentrations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17379167      PMCID: PMC1885230          DOI: 10.1016/j.nano.2006.11.005

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  19 in total

Review 1.  Development of biomaterials for gene therapy.

Authors:  S Han; R I Mahato; Y K Sung; S W Kim
Journal:  Mol Ther       Date:  2000-10       Impact factor: 11.454

2.  Cellular interactions and in vitro DNA transfection studies with poly(ethylene glycol)-modified gelatin nanoparticles.

Authors:  Goldie Kaul; Mansoor Amiji
Journal:  J Pharm Sci       Date:  2005-01       Impact factor: 3.534

Review 3.  Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery.

Authors:  Vinod Labhasetwar
Journal:  Curr Opin Biotechnol       Date:  2005-11-02       Impact factor: 9.740

Review 4.  Long-circulating polymeric nanovectors for tumor-selective gene delivery.

Authors:  Sushma Kommareddy; Sandip B Tiwari; Mansoor M Amiji
Journal:  Technol Cancer Res Treat       Date:  2005-12

5.  Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione.

Authors:  Sushma Kommareddy; Mansoor Amiji
Journal:  Bioconjug Chem       Date:  2005 Nov-Dec       Impact factor: 4.774

Review 6.  Barriers to gene delivery using synthetic vectors.

Authors:  Martin L Read; Ann Logan; Leonard W Seymour
Journal:  Adv Genet       Date:  2005       Impact factor: 1.944

7.  Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies.

Authors:  Goldie Kaul; Mansoor Amiji
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

8.  Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model.

Authors:  Goldie Kaul; Mansoor Amiji
Journal:  J Drug Target       Date:  2004       Impact factor: 5.121

9.  Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice.

Authors:  Sushma Kommareddy; Mansoor Amiji
Journal:  J Pharm Sci       Date:  2007-02       Impact factor: 3.534

10.  Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery.

Authors:  Goldie Kaul; Mansoor Amiji
Journal:  Pharm Res       Date:  2002-07       Impact factor: 4.200

View more
  25 in total

1.  Multi-compartmental nanoparticles-in-emulsion formulation for macrophage-specific anti-inflammatory gene delivery.

Authors:  Husain Attarwala; Mansoor Amiji
Journal:  Pharm Res       Date:  2012-01-27       Impact factor: 4.200

Review 2.  Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.

Authors:  Lara Milane; Shanthi Ganesh; Shruti Shah; Zhen-Feng Duan; Mansoor Amiji
Journal:  J Control Release       Date:  2011-04-08       Impact factor: 9.776

3.  Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen.

Authors:  Punit P Shah; Pinaki R Desai; Mandip Singh
Journal:  J Control Release       Date:  2011-11-21       Impact factor: 9.776

4.  Biodistribution and pharmacokinetics of EGFR-targeted thiolated gelatin nanoparticles following systemic administration in pancreatic tumor-bearing mice.

Authors:  Jing Xu; Florence Gattacceca; Mansoor Amiji
Journal:  Mol Pharm       Date:  2013-04-16       Impact factor: 4.939

5.  Preparation, physicochemical characterization and cytotoxicity in vitro of gemcitabine-loaded PEG-PDLLA nanovesicles.

Authors:  Lin Jia; Jian-Jun Zheng; Shu-Man Jiang; Kai-Hong Huang
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

Review 6.  Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery.

Authors:  Jing Xu; Shanthi Ganesh; Mansoor Amiji
Journal:  Int J Pharm       Date:  2011-05-19       Impact factor: 5.875

7.  Temperature-triggered enzyme immobilization and release based on cross-linked gelatin nanoparticles.

Authors:  Zhenhai Gan; Ting Zhang; Yongchun Liu; Daocheng Wu
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

Review 8.  Environmentally responsive peptides as anticancer drug carriers.

Authors:  Suhaas Aluri; Siti M Janib; J Andrew Mackay
Journal:  Adv Drug Deliv Rev       Date:  2009-07-20       Impact factor: 15.470

Review 9.  Gelatin carriers for drug and cell delivery in tissue engineering.

Authors:  Marco Santoro; Alexander M Tatara; Antonios G Mikos
Journal:  J Control Release       Date:  2014-04-16       Impact factor: 9.776

10.  Epidermal growth factor receptor-targeted gelatin-based engineered nanocarriers for DNA delivery and transfection in human pancreatic cancer cells.

Authors:  Padmaja Magadala; Mansoor Amiji
Journal:  AAPS J       Date:  2008-11-26       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.